Rx Propellant to set up Rs 1,100 cr lab in HyderabadIllustrative image – not actual.
Rx Propellant has made an investment of Rs 1,100 crore, its first from USD 200 million that global fund Actis infused in the life-sciences real estate development platform, to develop a lab space at Genome Valley in Hyderabad, Telangana. 
 
The company plans to develop a 9,00,000 sq ft lab space. The lab will be operational over mid-2025. 
 
The new cluster will cater to startups, scale-ups and established contract manufacturers and multinationals in the pharma space. 
 
RX Propellant has already invested Rs 900 crore in the development of its existing life-sciences infrastructure. 
 
It is planning to infuse another Rs 2,000 crore to build over 10 million sq ft of lab space over the next five years across Hyderabad, Bengaluru and Navi Mumbai. 
 
The company currently has half a million square feet of operational life-sciences real estate space in Hyderabad and Bengaluru.
← All latest storiesBack to top →